Advertisement
#Open journalism No news is bad news

Your contributions will help us continue to deliver the stories that are important to you

Support The Journal
Dublin: 5°C Monday 24 January 2022

#sma

# sma - Tuesday 11 June, 2019

Spinraza campaigners 'finally have hope' as HSE approves access to drug for rare disease
# Sma
# Sma

Spinraza campaigners 'finally have hope' as HSE approves access to drug for rare disease

Jun 11th 2019, 2:00 PM 8,621 Views 5 Comments

The drug has been approved for children with SMA Type I, II or III on “an exceptional and individualised basis”.

# sma - Wednesday 15 May, 2019

'We need to do right by families': Call for HSE to fund drug for rare disease after NHS approval
# Spinraza
# Spinraza

'We need to do right by families': Call for HSE to fund drug for rare disease after NHS approval

May 15th 2019, 12:29 PM 6,251 Views 4 Comments

Spinal muscular atrophy weakens muscles and causes problems with movement, breathing and swallowing.

# sma - Sunday 10 March, 2019

'We are failing these children spectacularly': Row over drug with 'exorbitant' cost rumbles on
# Spinraza
# Spinraza

'We are failing these children spectacularly': Row over drug with 'exorbitant' cost rumbles on

Mar 10th 2019, 8:00 AM 9,231 Views 13 Comments

Negotiations, and clashes, over the price of Spinraza are ongoing behind the scenes.

# sma - Thursday 28 February, 2019

'Look in my child's eyes and tell him his life is not worth saving': Parents call for access to medication
# Spinraza
# Spinraza

'Look in my child's eyes and tell him his life is not worth saving': Parents call for access to medication

Feb 28th 2019, 12:52 PM 10,381 Views 28 Comments

About 26 children with SMA, a rare muscle-wasting condition, could benefit from Spinraza.

# sma - Monday 25 February, 2019

'A price has been put on the value of life': HSE will not reimburse drug for children with rare condition
# Spinraza
# Spinraza

'A price has been put on the value of life': HSE will not reimburse drug for children with rare condition

Updated Feb 25th 2019, 7:54 PM 23,340 Views 62 Comments

The HSE said the current price of Spinraza – more than €20 million over five years – is not cost-effective.

# sma - Sunday 3 February, 2019

'You wouldn't tell a child they couldn't have chemo, but our son is being denied the medication he needs'
# Spinraza
# Spinraza

'You wouldn't tell a child they couldn't have chemo, but our son is being denied the medication he needs'

Feb 3rd 2019, 4:00 PM 19,326 Views 17 Comments

Parents of children with a rare genetic condition are fighting for access to a potentially life-changing drug.

# sma - Saturday 7 January, 2017

'If she gets another chest infection she probably won't make it, that’s the reality'
# SPINAL MUSCULAR ATROPHY
# SPINAL MUSCULAR ATROPHY

'If she gets another chest infection she probably won't make it, that’s the reality'

Jan 7th 2017, 7:25 AM 31,738 Views 16 Comments

Nellie and Lara are the only two children in Ireland with Spinal Muscular Atrophy Type 1 – an extremely rare genetic condition.

# sma - Friday 28 December, 2012

Small and medium businesses could* deliver 20,000 jobs
# Jobswatch
# Jobswatch

Small and medium businesses could* deliver 20,000 jobs

Dec 28th 2012, 6:45 AM 2,841 Views 11 Comments

The Small Firms Association makes optimistic prediction for 2013 – *but only if SMEs are “placed at the heart of economic policy”.